338 related articles for article (PubMed ID: 7684684)
1. A pattern search method for putative anchor residues in T cell epitopes.
Hobohm U; Meyerhans A
Eur J Immunol; 1993 Jun; 23(6):1271-6. PubMed ID: 7684684
[TBL] [Abstract][Full Text] [Related]
2. Exact prediction of a natural T cell epitope.
Rötzschke O; Falk K; Stevanović S; Jung G; Walden P; Rammensee HG
Eur J Immunol; 1991 Nov; 21(11):2891-4. PubMed ID: 1718764
[TBL] [Abstract][Full Text] [Related]
3. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.
Leighton J; Sette A; Sidney J; Appella E; Ehrhardt C; Fuchs S; Adorini L
J Immunol; 1991 Jul; 147(1):198-204. PubMed ID: 1711074
[TBL] [Abstract][Full Text] [Related]
4. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
[TBL] [Abstract][Full Text] [Related]
5. Definition of specific peptide motifs for four major HLA-A alleles.
Kubo RT; Sette A; Grey HM; Appella E; Sakaguchi K; Zhu NZ; Arnott D; Sherman N; Shabanowitz J; Michel H
J Immunol; 1994 Apr; 152(8):3913-24. PubMed ID: 8144960
[TBL] [Abstract][Full Text] [Related]
6. Class I MHC-peptide interaction: structural and functional aspects.
Ruppert J; Kubo RT; Sidney J; Grey HM; Sette A
Behring Inst Mitt; 1994 Jul; (94):48-60. PubMed ID: 7998914
[TBL] [Abstract][Full Text] [Related]
7. Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103).
Reay PA; Kantor RM; Davis MM
J Immunol; 1994 Apr; 152(8):3946-57. PubMed ID: 7511662
[TBL] [Abstract][Full Text] [Related]
8. Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.
Kast WM; Brandt RM; Sidney J; Drijfhout JW; Kubo RT; Grey HM; Melief CJ; Sette A
J Immunol; 1994 Apr; 152(8):3904-12. PubMed ID: 7511661
[TBL] [Abstract][Full Text] [Related]
9. The interaction of antigenic peptides with the H-2Kd MHC class I molecule.
Maryanski JL; Lüthy R; Romero P; Healy F; Drouet C; Casanova JL; Jaulin C; Kourilsky P; Corradin G
Semin Immunol; 1993 Apr; 5(2):95-104. PubMed ID: 8504219
[TBL] [Abstract][Full Text] [Related]
10. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
[TBL] [Abstract][Full Text] [Related]
11. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
[TBL] [Abstract][Full Text] [Related]
12. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif.
Lipford GB; Hoffman M; Wagner H; Heeg K
J Immunol; 1993 Feb; 150(4):1212-22. PubMed ID: 7679422
[TBL] [Abstract][Full Text] [Related]
13. A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes.
Reddehase MJ; Rothbard JB; Koszinowski UH
Nature; 1989 Feb; 337(6208):651-3. PubMed ID: 2465495
[TBL] [Abstract][Full Text] [Related]
14. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J
Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315
[TBL] [Abstract][Full Text] [Related]
15. MUC1 peptide epitopes associated with five different H-2 class I molecules.
Apostolopoulos V; Haurum JS; McKenzie IF
Eur J Immunol; 1997 Oct; 27(10):2579-87. PubMed ID: 9368613
[TBL] [Abstract][Full Text] [Related]
16. Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8.
DiBrino M; Parker KC; Shiloach J; Turner RV; Tsuchida T; Garfield M; Biddison WE; Coligan JE
J Immunol; 1994 Jan; 152(2):620-31. PubMed ID: 7506728
[TBL] [Abstract][Full Text] [Related]
17. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs.
Rudensky AYu ; Preston-Hurlburt P; al-Ramadi BK; Rothbard J; Janeway CA
Nature; 1992 Oct; 359(6394):429-31. PubMed ID: 1328884
[TBL] [Abstract][Full Text] [Related]
18. Binding of peptides lacking consensus anchor residue alters H-2Ld serologic recognition.
Solheim JC; Carreno BM; Smith JD; Gorka J; Myers NB; Wen Z; Martinko JM; Lee DR; Hansen TH
J Immunol; 1993 Nov; 151(10):5387-97. PubMed ID: 7693810
[TBL] [Abstract][Full Text] [Related]
19. A molecular basis for how a single TCR interfaces multiple ligands.
Boesteanu A; Brehm M; Mylin LM; Christianson GJ; Tevethia SS; Roopenian DC; Joyce S
J Immunol; 1998 Nov; 161(9):4719-27. PubMed ID: 9794402
[TBL] [Abstract][Full Text] [Related]
20. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
